Quantcast

Latest Genzyme Stories

2014-09-10 12:28:37

Major five-year grant with Canadian Consortium on Neurodegeneration in Aging (CCNA) will fund transformative research into disease prevention and treatment MONTREAL, Sept.

2014-08-13 16:25:52

-- 2Q Revenue Increased 71%, Compared to Prior Year -- SOUTH SAN FRANCISCO, Calif., Aug.

2014-07-31 04:22:57

PARIS, July 31, 2014 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first half of 2014.

2014-07-03 12:26:08

STOCKHOLM, July 3, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, is very pleased to announce that Mrs Ann-Tove Kongsnes,

2014-06-12 12:30:07

Current Neurologist-Reported Patient Share for Tecfidera Exceeds that of Genzyme's Aubagio and Novartis's Gilenya Combined, According to Findings from Decision Resources Group BURLINGTON, Mass.,

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-05-15 12:29:33

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:

2014-05-08 08:34:19

ROCKVILLE, Md., May 8, 2014 /PRNewswire/ -- Neuralstem, Inc.

2014-05-01 12:32:03

- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related